CERS Q2 2021 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M+46.4% YoY

Gross Profit

$16M51.3% margin

Operating Income

-$14M-45.7% margin

Net Income

-$15M-48.8% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+34.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$223M

Total Liabilities

$139M

Stockholders' Equity

$84M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$22M	+46.4%
Gross Profit	$16M	$12M	+37.0%
Operating Income	-$14M	-$15M	+1.4%
Net Income	-$15M	-$15M	-3.3%

Revenue Segments

Government Contract

$6M100%

Geographic Segments

Europe Middle East And Africa

$16M52%

North America

$15M47%

Other

$606,0002%